ICD-10 Specific code D65: Disseminated intravascular coagulation [defibrination syndrome]
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Disseminated intravascular coagulation [defibrination syndrome] |
French
|
Coagulation intravasculaire disséminée [syndrome de défibrination] |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | III | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | |
| 2 | D65-D69 | Coagulation defects, purpura and other haemorrhagic conditions | |
| 3 | D65 | Disseminated intravascular coagulation [defibrination syndrome] |
Indicated medicines
| Active Ingredient |
|---|
|
Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid. Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid. Tranexamic acid binds more strongly than aminocaproic acid to both the strong and weak receptor sites of the plasminogen molecule in a ratio corresponding to the difference in potency between the compounds. |